AWM
TEVA icon

Activest Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Activest Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,826
Closed -$32K – 610
2024
Q2 		$29.7K Hold
1,826
– – 0.01% 214
2024
Q1 		$25.8K Hold
1,826
– – 0.01% 158
2023
Q4 		$19.1K Buy
+1,826
New +$17K 0.01% 155
2023
Q3 		– Sell
-1,826
Closed -$15.4K – 391
2023
Q2 		$15.4K Hold
1,826
– – 0.01% 141
2023
Q1 		$16.2K Buy
+1,826
New +$18.1K 0.01% 135
2022
Q3 		– Sell
-1,826
Closed -$14K – 597
2022
Q2 		$14K Buy
1,826
+1,242
+213% +$10.8K 0.01% 181
2022
Q1 		$5K Buy
+584
New +$4.87K ﹤0.01% 260
2021
Q4 		– Sell
-1,014
Closed -$10K – 403
2021
Q3 		$10K Hold
1,014
– – 0.01% 229
2021
Q2 		$10K Hold
1,014
– – 0.01% 201
2021
Q1 		$12K Buy
+1,014
New +$11.6K 0.01% 176

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Activest Wealth Management's TEVA Position: Q3 2024 in Review

Activest Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2024, closing a stake of 1,826 shares — an estimated $32K sold.

Activest Wealth Management first reported a position in TEVA in Q1 2021 and held it in 10 quarters. The position peaked at $29.7K in Q2 2024. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Activest Wealth Management reported no remaining Teva Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Activest Wealth Management sold 1,826 Teva Pharmaceuticals shares in Q3 2024, an estimated $32K.
  • Activest Wealth Management first reported a position in Teva Pharmaceuticals in Q1 2021 and held it in 10 quarters.
  • Activest Wealth Management's Teva Pharmaceuticals position peaked at $29.7K in Q2 2024.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on Activest Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.